International Variation in Drug Usage
A new RAND study explores the range of possible causes that might explain observed international variations in the usage of medicines for selected disease areas: dementia, osteoporosis, cancer, diabetes, and hepatitis C.
Numbers for First Week of Open Enrollment Now Available
More than 1 million Americans applied for coverage through the federal Marketplace during the first week of open enrollment, HHS reported in the first of its weekly data snapshots.
AJMC Study Finds CMS Fee Schedule Doesn’t Pay Doctors Enough to Care for Complex Patients
The call for value-based care is propelled by the shortage of family physicians and the disparity connection between the time it takes to care for the sickest patients and what Medicare and Medicaid pay. A study in this month’s issue of The American Journal of Managed Care tracks just how bad things are, by looking at a normal day in a family practice.
Researchers Identify Barriers to Sharing Public Health Data
Attempts to contain emerging global health threats, like the current Ebola outbreak in West Africa, are hampered by barriers to sharing public health data, according to an international team of researchers.
Yale Study Shows PD-L1 Expression Can Predict Response to PD-L1 Inhibitors
The trial, conducted across various tumor types, monitored PD-L1 expression in biopsy samples before and during treatment with the PD-L1 inhibitor MPDL3280A being developed by Genentech.
Eric Schneider to Join The Commonwealth Fund
Eric C. Schneider, MD, senior principal researcher and distinguished chair in health care quality at RAND, and director of its Boston office, will join The Commonwealth Fund as senior vice president for policy and research on February 2, 2015.
Alarm Hazards Remain Top Safety Concern in Hospitals
Medical technology hazards remain a top safety issue for hospitals and can come in many forms. However, for the fourth year in a row, alarm hazards topped the annual Top 10 Health Technology Hazards list from the ECRI Institute.
Pre-Op Work Can Prevent Risks Associated With Morcellation: Study Finds
Following on the heels of the FDA's advice on the risk of using morcellators for treating fibroids, researchers in France have released results of a study that delineates a method that can avoid the risk of morcellating a pre-existing uterine sarcoma.
How Medicaid Reimbursements Impact Cancer Screening Rates
Physicians who receive higher reimbursements for routine office visits are more likely to perform cancer screening tests on Medicaid beneficiaries, according to a new study in Cancer.
A 2-Drug Combination Successfully Thwarts Colorectal Cancer
A study by the University of Colorado Cancer Center published in the journal PLoS ONE and concurrent phase I clinical trial is examining a new strategy: targeting both important cancer-causing pathways simultaneously.
A Small Business Owner's Woes With the ACA
A small business owner describes his experience with buying health benefit for his employees through the Affordable Care Act plans.
Civil Unrest in Ferguson Tests St. Louis Area Hospitals
Hospitals in the St. Louis area braced for another violent night Tuesday after at least 25 people were injured in riots triggered by a grand jury's decision not to indict Ferguson, Missouri, police officer Darren Wilson in the fatal shooting of Michael Brown.
Employers Looking to Make Health Plan Changes in 2015
Few employers are planning to eliminate their health benefits in 2015, but they are still looking to make noticeable changes, according to a report from the Employee Benefit Research Institute.
Gene that Could Identify Tamoxifen-Resistant Breast Cancer Discovered
The study, published in PNAS, identified a gene whose expression could be used as a prognostic indicator and could direct treatment in breast cancer patients.
CMS Extends Deadline for Meaningful Use Attestation
The deadline for eligible hospitals and critical access hospitals to attest to meeting meaningful use requirements has been pushed back a full month, according to CMS.
Restricted Specialty Drug Distribution Could Raise Cancer Drug Costs
Genentech's decision to use a handful of specialty drug distributors instead of wholesalers for the distribution of the most commonly used anticancer medications has raised concerns of availability and cost.
Caloric Information Needed in Chain Restaurants and Vending Machines: FDA
The rule applies to restaurants, retail food establishments, and vending machines with 20 or more locations.
Study Strengthens Link Between Obesity and Prostate Cancer
The large retrospective study, conducted in 9.8 million men, identified a strong association between obesity and the development of an advanced and more aggressive form of the disease.
AJMC Article Explores Reducing the Confusion Between Branded and Generic Drugs
A commentary in this month’s issue of The American Journal of Managed Care explores whether allowing generic versions of medications to look like branded equivalents would be better for consumers and improve adherence.
HHS Proposes Fixed Open Enrollment Dates, Automatic Re-Enrollment Alternatives
In the first 2 years of the Affordable Care Act, open enrollment has run for 2 different time periods, and HHS is looking to set a fixed date for future years. Plus, it offers a solution to automatic re-enrollment.
Amgen's Rilotumumab Fails...Again
The monoclonal antibody,a c-Met inhibitor, was being tested in advanced gastric cancer patients following it's revival 2 years back.
FDA Update on the Use of Power Morcellators
In the update, the FDA is now asking the device manufacturers to include a black box warning and contraindications, to warn both providers and patients of possible health risks with the procedure.
The Road to Extinction: Oncology Private Practice
This article in The New York Times details the reasons why private oncology practices are being forced to consolidate to stay afloat.
Seeking the Right to Try
Laws allowing terminal patients to try drugs not approved by the FDA have passed in five states, but experts question their efficacy.
Northwestern Study Discovers Treatment For Pediatric Gliomas
The study, published in Nature Medicine, identified a small molecule inhibitor that increases histone methylation, compensating for the reduced methylation caused by mutation in the H3F3A gene, resulting in gliomas.